Liu Chung Ming Clara, Wang Xiaowei, Gentile Carmine
School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW, Australia.
Cardiovascular Regeneration Group, Heart Research Institute, Newtown, NSW 2042, Australia.
iScience. 2024 Aug 14;27(9):110726. doi: 10.1016/j.isci.2024.110726. eCollection 2024 Sep 20.
This review explores the roles of the cholinergic system in the heart, comprising the neuronal and non-neuronal cholinergic systems. Both systems are essential for maintaining cardiac homeostasis by regulating the release of acetylcholine (ACh). A reduction in ACh release is associated with the early onset of cardiovascular diseases (CVDs), and increasing evidence supports the protective roles of ACh against CVD. We address the challenges and limitations of current strategies to elevate ACh levels, including vagus nerve stimulation and pharmacological interventions such as cholinesterase inhibitors. Additionally, we introduce alternative strategies to increase ACh in the heart, such as stem cell therapy, gene therapy, microRNAs, and nanoparticle drug delivery methods. These findings offer new insights into advanced treatments for regenerating the injured human heart.
本综述探讨了胆碱能系统在心脏中的作用,包括神经元性和非神经元性胆碱能系统。这两个系统对于通过调节乙酰胆碱(ACh)的释放来维持心脏稳态至关重要。ACh释放减少与心血管疾病(CVD)的早期发作有关,越来越多的证据支持ACh对CVD的保护作用。我们阐述了当前提高ACh水平策略的挑战和局限性,包括迷走神经刺激和诸如胆碱酯酶抑制剂等药物干预措施。此外,我们介绍了增加心脏中ACh的替代策略,如干细胞疗法、基因疗法、微小RNA和纳米颗粒药物递送方法。这些发现为受损人类心脏再生的先进治疗提供了新的见解。